EMA/PE/0000181778 - paediatric investigation plan

rilvegostomig

Key facts

• Active substance:
  rilvegostomig
• Therapeutic area:
  Gastrointestinal disorders
• Decision number:
  EMA/PE/0000181778
• PIP number:
  EMA/PE/0000181778
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Treatment of gastric and gastroesophageal junction adenocarcinoma
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  06/12/2024
• Compliance check done:
  No

Decision

EMA/PE/0000181778: EMA decision of 6 December 2024 on the granting of a product specific waiver for rilvegostomig

Adopted Reference Number: EMADOC-1700519818-1793273